CD38 and neoplasm: Although works by Caserta et al. and Ghai et al. have demonstrated that anti-CD38 imaging is feasible, the relevance of clinical translation is still hampered by the fact that biodistribution and tumour uptake in relation to healthy tissues could not be properly evaluated, tumour xenografts being unrealistically the only site of target expression.